Pfizer COVID-19 Vaccine Clinic

We are a Pfizer COVID-19 GP Vaccination Clinic for eligible Medicare card holders.
Book your appointment online or call us on (03) 9629 1414.

Bulk Billed  *  By appointment only  *  No walk-ins

Victoria Harbour Medical Centre is an approved Pfizer (Comirnaty) COVID-19 general practice vaccination clinic for eligible Medicare card holders.  We are an inclusive medical service and proudly support the health care needs of the LGBTIQA+ community. 

To be fully vaccinated, you need to have 2 doses of the same vaccine. You cannot mix vaccines in your primary course of vaccination, unless you have experienced a severe reaction from the first dose. Booster doses are now recommended as per ATAGI and Department of Health guidelines. 

We no longer offer the AstraZeneca (Vaxzervia) COVID-19 vaccine.  We do not offer the Moderna (Spikevax) COVID-19 vaccine.  Refer to the Department of Health website for an AstraZeneca (Vaxzervia) or Moderna (Spikevax) COVID-19 vaccine appointment.

Pfizer COVID-19 vaccine appointments now available to:

  • Anyone > 12 years old
  • Booster doses for anyone > 18 year old
  • Pregnant women (any stage of pregnancy)
  • Children aged 5-11 years old – from 10/01/2022 – call for an appointment
  • Third (primary) and fourth (booster) doses for immunocompromised people (>12 years old)
  • Third primary dose for immunocompromised children (5-11 years old)
Please Note: Only one parent/guardian permitted to attend our vaccination clinic to accompany a young person aged 5-17 years old.

Recommended Pfizer COVID-19 vaccine dose interval (updated 19/02/2022):

  • Dose 2 (>12 years old):
    • 3 weeks after Dose 1.
  • Dose 2 (5-11 years old):
    • 8 weeks after Dose 1.*
  • Dose 3 “Booster” (>18 years old):
    • 3 months after Dose 2.
  • Third primary dose for immunocompromised people (>12 years old):
    • 2 months after Dose 2.**
  • Third primary dose for immunocompromised children (5-11 years old):
    • 2 to 6 months after Dose 2.***
  • Fourth (booster) dose for immunocompromised people (>12 years old):
    • 4 months after Dose 3.

You need your third dose to keep up your immunity against COVID-19.  Your vaccinator will exercise discretion in determining what dose interval to use (in line with Department of Health guidelines). Call our medical centre for all enquires on (03) 9629 1414.

Paediatric Pfizer COVID-19 vaccine for children 5-11 years old:

  • Click here to view ATAGI recommendations.
  • Pfizer is the only COVID-19 vaccine approved for use in this age group.
  • The recommended dose for this age group is 10µg (0.2mL),  a third of the recommended 30µg dose for people aged  > 12 years old.  
  • * The primary course is 2 doses, with an interval of 8 weeks – the interval can be shortened to a minimum of 3 weeks in special circumstances.
  • Children who turn 12 after Dose 1 can receive the adolescent/adult formation of the Pfizer COVID-19 vaccine to complete their primary vaccine course.
  • The paediatric Pfizer COVID-19 vaccine can be co-administered with other vaccines.

Pfizer Booster (Third) doses:

  • Click here to view ATAGI recommendations.
  • Click here to view Department of Health recommendations.
  • Eligible to > 18 years olds who have had Dose 2 of a COVID-19 vaccine > 4 months ago.
  • If you’ve had Dose 2 four months ago or earlier, you are now due for Dose 3.
  • You need Dose 3 to keep up your immunity against COVID-19.
  • Booster doses can be co-administered with the influenza vaccine.
  • You can safely get a Pfizer (Comirnaty) COVID-19 vaccine booster dose regardless of which COVID-19 vaccine you received for your initial 2 doses (primary course).
  • The AstraZeneca (Vaxzevria) COVID-19 vaccine is not preferred for use as a booster dose, but it can be used in individuals who have received an AstraZeneca (Vaxzevria) COVID-19 vaccine for their first two doses if there are no contraindications or precautions for use, or a significant adverse reaction has occurred after a previous mRNA vaccine dose which contraindicates further doses of mRNA vaccine.
  • You can also get a booster dose if you have completed an initial COVID-19 vaccination course overseas with a COVID-19 vaccine recognised by the TGA.

Third (primary) and fourth (booster) doses for immunocompromised people > 12 years old:

  • Eligibility criteria apply.
  • Click here to view ATAGI recommendations.
  • Third primary doses of the COVID-19 vaccine for people who are severely immunocompromised are provided as part of the primary course, they are not boosters. 
  • Third primary doses are different to booster doses because they are given to those who are immune suppressed so they can have the same level of protection as the general population. 
  • **ATAGI recommends the interval for the third dose is 2 to 6 months after Dose 2 of the vaccine – a minimum interval of 4 weeks may be considered in exceptional circumstances (eg: outbreaks, anticipated intensification of immunosuppression).
  • Fourth (booster) doses for people with severe immunocompromise are now recommended and should be given four months after the third primary dose in line with the timing for the general population.

Third (primary) dose for immunocompromised children 5-11 years old:

  • Click here to view ATAGI recommendations.
  • *** ATAGI recommends severely immunocompromised children aged 5-11 years old are now recommended to receive a third primary dose of the Pfizer COVID-19 vaccine 2 to 6 months after their second dose (in line with other severely immunocompromised age cohorts).

DO NOT attend our vaccination clinic if:

If you have a booked appointment and you are unwell please advise us  and DO NOT attend the vaccination clinic. Even if you have mild symptoms you should get a COVID-19 test and isolate until you have a negative result.

Prizer COVID-19 vaccine Consumer Medicine Information (CMI):

  • Click here to learn more about the Pfizer COVID-19 vaccine.
  • Click here for TGA CMI Pfizer COVID-19 vaccine handout.

How to get proof of your COVID-19 vaccination:

  • Click here to find out how to get proof of your COVID-19 vaccination and view your COVID-19 digital certificate.
  • You can also refer to this RACGP Fact Sheet.

Other information:

  • Click here for digital information from the Department of Health.
  • Call the COVID-19 Vaccine Hotline on tel 1800 675 398
While the Australian Government strongly supports vaccination, the COVID-19 vaccine is not mandatory and individuals may choose not to vaccinate. CoRiCal is a vaccine risk calculator tool which aims to help people make informed decisions about the risks versus benefits of COVID-19 vaccines. Please discuss with your GP.

For Pfizer (Comirnaty) COVID-19 vaccine bookings (aged >12 years old):

For Pfizer (Comirnaty) COVID-19 vaccine bookings (aged 5-11 years old):

Note: Only one parent/guardian permitted to attend our vaccination clinic to accompany a young person aged 5-17 years old.

DO NOT attend our vaccination clinic if:

If you have a booked appointment and you are unwell please advise us  and DO NOT attend the vaccination clinic. Even if you have slight symptoms you should get a COVID-19 test and isolate until you have a negative result.

Anyone who presents for vaccination must provide informed consent.

Consent can be provided verbally or by completing this written consent form.

For young people aged 12-17 years old consent may be established by:

Click here to check your eligibility online.

The following people are now eligible to receive the Pfizer (Comiranty) COVID-19 vaccine at our medical centre:

  • Anyone > 12 years old
  • Booster doses for > 18 year olds
  • Pregnant women (any stage of pregnancy)
  • Children aged 5-11 years old – from 10/01/2022 – call to join our waitlist
  • Third primary and fourth booster doses for immunocompromised people (>12 years old) – eligibility criteria apply

Our medical centre no longer offers the AstraZeneca (Vaxzervia) COVID-19 vaccine.  We do not offer the Moderna (Spikevax) COVID-19 vaccine.  Refer to the Department of Health for an AstraZeneca (Vaxzervia) or Moderna (Spikevax) COVID-19 vaccine appointment.

  • Bulk Billed
  • No walk-ins
  • Eligible Medicare card holders only
  • By appointment only based on vaccine stock availability

Please download and bring your COVID-19 vaccine Consent Form to your appointment.

If you are new to our medical centre and attend for a COVID-19 vaccination, you may need to provide evidence of your eligibility (eg: medical history, occupation, age) before you can receive your COVID-19 vaccine.  This evidence can be an identification card, proof of current employment, a letter from your usual doctor, or by ensuring your My Health Record contains a current Shared Health Summary which we can access during your consultation.

DO NOT attend our vaccination clinic if:

If you have a booked appointment and you are unwell please advise us  and DO NOT attend the vaccination clinic. Even if you have mild symptoms you should get a COVID-19 test and isolate until you have a negative result.

Click here to find out how to get proof of your COVID-19 vaccination and view your COVID-19 digital certificate.  You can also refer to this RACGP Fact Sheet.

Due to the Australian Government current funding model, people who are not eligible for Medicare will be unable to receive the COVID-19 vaccine through community general practice clinics including Victoria Harbour Medical Centre.  This means vaccine access for non-Medicare card holders can only be delivered by:

For all enquires call the COVID-19 Vaccine Hotline on 1800 675 398.

There are some things you can do to get ready for your COVID-19 vaccine:

  • Click here to find out what you should do before you get vaccinated for COVID-19.
  • Click here to download a fact sheet about preparing for the COVID-19 vaccination.
  • Click here for information about side effects and after care following your COVID-19 vaccine.
  • Click here to subscribe for email updates about to the COVID-19 vaccination.
  • Book a Telehealth consultation with one of our GPs to discuss your concerns.
  • Call the Victorian COVID-19 Vaccine Hotline on tel 1800 675 398.

Information about the COVID-19 vaccine has been translated into multiple languages.  To find information in your language:

Australian Department of Health website click here.

Victorian Department of Health website click here.

On 02/06/2021 ATAGI (Australian Technical Advisory Group on Immunisation) clinical guidance on COVID-19 vaccines in Australia includes the following:

  • A minimum 7-day interval is advised between administration of a COVID-19 vaccine and any other vaccine, including the Flu vaccine
  • This interval can be shortened (including same day administration) in special circumstances
  • Co-administration of COVID-19 vaccine with other vaccines is not routinely recommended

Due to the current COVID-19 outbreak in Victoria, changes in recommendation to the timing of influenza and COVID-19 vaccines for certain groups is required.  In order to ensure that all residents and staff in residential aged care and disability care settings are vaccinated as soon as possible, the previous minimum interval between the Flu vaccine and the COVID-19 vaccine no longer applies for this group.

The Australian Department of Health has updated the COVID-19 vaccination decision-making guide for women who are pregnant, breastfeeding, or planning pregnancy.

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) have provided updated advice from 18th August 2021 about the COVID-19 vaccine in pregnant and breastfeeding Women and those planning pregnancy.

Key points:

  • Pregnant women are a priority group for COVID-19 vaccination.
  • Pregnant women should be routinely offered the Pfizer (Comirnaty) or Spikevax (Moderna) COVID-19 vaccine at any stage of pregnancy. 
  • Pfizer (Comirnaty) and Spikevax (Moderna) are mRNA vaccines
  • Women who are trying to become pregnant do not need to delay vaccination or avoid becoming pregnant after vaccination. 
  • There is no evidence of increased risk of miscarriage or teratogenic risk with mRNA or viral vector vaccines.
  • Global evidence has shown that the Pfizer and Moderna COVID-19 vaccines are safe for pregnant women. 
  • Pregnant women have a higher risk of severe illness from COVID-19. 
  • Their babies also have a higher risk of being born prematurely. 
  • COVID-19 vaccination may provide indirect protection to babies by transferring antibodies through the placenta (for pregnant women) or through breastmilk (for breastfeeding women).

Women who received their first dose of the AstraZeneca COVID-19 vaccine and are pregnant can receive either Dose 2 of the AstraZeneca COVID-19 vaccine or the Pfizer COVID-19 vaccine, although the Pfizer or Moderna COVID-19 vaccine is preferred.  Pregnant women should speak with their health care provider about the best choice for them. 

In summary:

  • Pregnant women are a priority group for COVID-19 vaccination, and should be routinely offered the Pfizer (Cominarty) or Spikevax (Moderna) COVID-19 vaccine at any stage of pregnancy.
  • COVID-19 vaccination is recommended for breastfeeding women –  either Pfizer, Moderna or AstraZeneca vaccine is considered safe during breastfeeding.

Medical advice for adults < 60 years old and the AstraZeneca (Vaxzevria) COVID-19 vaccine:  On 17/06/2021 the Australian Technical Advisory Group on Immunisation (ATAGI) advised the Pfizer COVID-19 vaccine is preferred over the AstraZeneca COVID-19 vaccine for adults aged < 60 years old.  This revised age recommendation is because of a higher risk of an extremely rare but serious side effect involving thrombosis (blood clotting) with thrombocytopenia (low blood platelet count) called TTS following the AstraZeneca COVID-19 vaccine in those aged < 60 years old.  The individual benefit-to-risk balance of vaccination with the AstraZeneca COVID-19 vaccine varies with age.  The AstraZeneca COVID-19 vaccine remains a safe and  highly effective at preventing death and severe illness among people who have contracted COVID-19. 

People who have already received the first dose of the AstraZeneca COVID-19 vaccine with no major adverse reaction are strongly encouraged to receive the second dose of the AstraZeneca COVID-19 vaccine as planned, including if they are < 60 years old.

The Melbourne Vaccine Education Centre has published this video that also helps to clearly explain TTS.

Medical advice for adults 18-59 years old and the AstraZeneca (Vaxzevria) COVID-19 vaccine:  On 29/06/2021 the Australian Department of Health advised the AstraZeneca COVID-19 vaccine can now be requested by adults aged 18-59 years old if they are unable to access a Pfizer COVID-19 vaccine.  It is important consumers weigh up the potential benefits and risk of harm from the AstraZeneca COVID-19 vaccine to ensure that they make a fully informed decision about receiving the vaccine.

Frequently Asked Questions:

What is the new ATAGI advice?  ATAGI have reviewed their advice on the AstraZeneca COVID-19 vaccine. They recommended the Pfizer COVID-19 vaccine is the preferred vaccine for people aged under 60 years.  This doesn’t change who is currently eligible for a COVID-19 vaccine, but it means if you are under 60 years old it is now preferred you get the Pfizer COVID-19 vaccine.

Why has the advice changed?  ATAGI have made this recommendation because of new evidence that shows the risk of thrombosis (blood clotting) with thrombocytopenia (low blood platelet count) or TTS (which is a rare blood clotting syndrome) following the first dose of the AstraZeneca COVID-19 vaccine in those aged < 60 years old is higher than initially thought.

I’ve had my first dose of the AstraZeneca (Vaxzevria) COVID-19 vaccine, should I get the Pfizer COVID-19 vaccine for my second dose?  No, this isn’t necessary. If you have had your first AstraZeneca COVID-19 vaccine dose without any serious side effects, you can receive your second dose as planned.  To ensure maximum long term immunity, it is important you receive two doses of the same COVID-19 vaccine.

I’ve had my first dose of the AstraZeneca (Vaxzevria) COVID-19 vaccine and have side effects that I am worried about. What should I do?  Discuss with your doctor or present to you local emergency department if you have recently had your first vaccine dose and are experiencing any side effects that you are worried about.  

I am 60 years or over, is the AstraZeneca (Vaxzevria) COVID-19 vaccine still safe for me?  Yes, the AstraZeneca COVID-19 vaccine is still safe for you.  The risk of thrombosis (blood clotting) with thrombocytopenia (low blood platelet count) or TTS (which is a rare blood clotting syndrome), is much lower in people aged 60 years and over.  Additionally, if you are aged 60 and over, you are much more likely to become seriously unwell if you catch COVID-19.  The individual benefit-to-risk balance of vaccination with the AstraZeneca COVID-19 vaccine varies with age. This balance is based on factors including the increased risk of complications from COVID-19 with increasing age and the potential lower risk of this very rare, but serious, adverse event with increasing age.   ATAGI has recommended the AstraZeneca COVID-19 vaccine remains safe to be given to people aged > 60 years old.

I am under 60 years old and I am fully vaccinated with the AstraZeneca (Vaxzevria) COVID-19 vaccine, do I have to get the Pfizer COVID-19 vaccine now?  If you have received both doses of the vaccine you do not need to get vaccinated with any other COVID-19 vaccine.

Name change: Why is the AstraZeneca COVID-19 vaccine now called Vaxzevria?  The name is now consistent with that used overseas, including in the European Union and Canada.  This is expected to alleviate confusion and further clarify that the vaccine produced by CSL and Seqirus in Melbourne is the same as that produced internationally.  This name change will also help facilitate international recognition for Australians who have been vaccinated with the AstraZeneca COVID-19 vaccine.  Importantly, this is the only change to the vaccine.  All other aspects, such as manufacturing and quality control, are unchanged and align with the way the vaccine is produced in other jurisdictions.

Change in AstraZeneca (Vaxzevria) COVID-19 vaccine dose interval from 02/09/2021:

  • The recommended minimum interval between first and second dose of the AstraZeneca COVID-19 vaccine will change to 6 weeks. Previously the recommended minimum interval was 12 weeks.
  • This change is consistent with advice from ATAGI.
  • This change is being made because of the current epidemiological conditions including community transmission of COVID-19.
  • Reducing the interval between doses will mean more Victorians are fully vaccinated with two doses as soon as possible.  
  • People can elect to change their vaccine appointment for their second dose of the AstraZeneca COVID-19 vaccine.
  • No existing second dose bookings at our medical centres will be proactively changed.
  • Your vaccinator may exercise their discretion in determining what dose interval to use (in line with ATAGI guidelines).

Click here for more information about the AstraZeneca COVID-19 vaccine.

Click here for more information on the AstraZeneca COVID-19 vaccine and thrombosis with thrombocytopenia syndrome (TTS).

What is the ATAGI advice on COVID-19 vaccinations for children aged 12 to 15? The Therapeutic Goods Administration (TGA) has approved the Pfizer COVID-19 vaccine for use in people aged 12-15 years.  The Australian Technical Advisory Group on Immunisation (ATAGI) has provided updated advice on eligibility criteria for vaccination with the Pfizer COVID-19 vaccine in children aged 12-15.  The Australian Government has accepted this advice.

When can eligible children start getting vaccinated?  All other children aged 12-15 years old will be eligible for the Pfizer COVID-19 vaccine from 13th September 2021.

Can eligible children receive the Pfizer COVID-19 vaccine at Victoria Harbour Medical Centre?  Yes.  Book your appointment with us online or call us on (03) 9629 1414.  Only one parent/guardian may attend our vaccination clinic with a young person aged 12-17 years old.

Where else can eligible children get their vaccination?  Parents/guardians can book a Pfizer COVID-19 vaccine for their child/children at:

  • state and territory-operated Pfizer clinics
  • participating general practices offering Pfizer
  • Commonwealth Vaccination Clinics offering Pfizer
  • Aboriginal Community Controlled Health Services offering Pfizer

You can make a booking by completing the COVID-19 Vaccine Eligibility Checker.

Information about consent for vaccination:

  • Anyone who presents for vaccination must provide informed consent
  • Consent can be provided verbally or by completing this written consent form
  • Consent for young people aged 12-17 years may be established by:
    • A  parent/guardian attending the vaccine appointment with the young person and provide consent for them
    • An unaccompanied young person may provide their own consent (mature minor) if deemed to be ‘Gillick competent’

More information is available on the Department of Health website.

Refer also to NCIRS COVID-19 and children FAQs.

ATAGI and the Department of Health have now recommended a booster dose of COVID-19 vaccine.

Click here for more information.

ATAGI has updated its advice on the use of a different COVID-19 vaccine as the second dose in special circumstances.

ATAGI recommends that, if available, the same COVID-19 vaccine brand should be used for the two doses of the primary vaccination course.

While it is preferable to use the same brand for both doses of the primary course, an alternative brand can be used for the second dose in select circumstances including if a patient is unable to access or is not accepting of a second dose of the same brand.

There is emerging data supporting the safety and efficacy of mixed brand schedules.

Click here for more information.

Following TGA approval of the Pfizer (Comirnaty) vaccine for children aged 5-11 years old, ATAGI has provided advice on administering vaccines to this age group.

  • The roll-out to this age group will commence from 10th January 2022.
  • Pfizer is the only COVID-19 vaccine that has been approved for use in this age group.
  • The recommended dose for this age group is 10µg  (0.2mL), a third of the recommended 30µg dose for people aged >12 years old.
  • Children who turn 12 after Dose 1 can receive the adolescent/adult formation of the Pfizer COVID-19 vaccine to complete their primary vaccine course.
  • The primary course is 2 doses, with an interval of 8 weeks – the interval can be shorted to a minimum of 3 weeks in special circumstances.

Click here for more information.

Click here for updated information on the Omicron variant and the timing of COVID-19 booster vaccination.

Click here to view updated Department of Health recommendations.